Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection

[1]  A. Phillips,et al.  Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. , 1974, Pharmacology, biochemistry, and behavior.

[2]  H F HUNT,et al.  SOME EFFECTS OF DRUGS ON CLASSICAL (TYPE S) CONDITIONING , 1956, Annals of the New York Academy of Sciences.

[3]  U. Ungerstedt,et al.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.

[4]  J. Gibbs,et al.  Behavioral responsiveness of adrenalectomized, hypophysectomized, and intact rats to electric shock. , 1973, Journal of comparative and physiological psychology.

[5]  H. Fibiger,et al.  Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome. , 1973, Brain research.

[6]  P. Mcgeer,et al.  CATECHOLAMINE CONTENT OF SPINAL CORD , 1962 .

[7]  R ADER,et al.  Effects of chlorpromazine on the acquisition and extinction of an avoidance response in the rat. , 1957, The Journal of pharmacology and experimental therapeutics.

[8]  A. Phillips,et al.  Reversal by L-Dopa of Impaired Learning Due to Destruction of the Dopaminergic Nigro-Neostriatal Projection , 1974, Science.

[9]  J. Davies,et al.  The effect of anti-Parkinsonian drugs on haloperidol-induced inhibition of the conditioned-avoidance response in rats. , 1973, Neuropharmacology.

[10]  A. Herz,et al.  Drugs and the conditioned avoidance response. , 1960, International review of neurobiology.

[11]  H. Fibiger,et al.  Attenuation of amphetamine‐induced motor stimulation and stereotypy by 6‐hydroxydopamine in the rat , 1973, British journal of pharmacology.

[12]  R. T. Kelleher,et al.  Effects of Drugs on Behavior , 1963 .

[13]  I. Mirsky,et al.  The effect of chlorpromazine on fear-motivated behavior in rats. , 1957, Journal of Pharmacology and Experimental Therapeutics.